Quanome Technologies, Inc.

Quanome Technologies, Inc.(QNME)股票分析

$0.383

+0.046 (+11.96%)收盘时

Loading chart…
最高
0.386
开盘
0.360
成交量加权均价
0.38
成交量
159.27K
市值
—
最低
0.360
成交额
59.95K
企业价值/息税折旧摊销前利润(TTM)
0.00

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

AI 分析 of Quanome Technologies, Inc. (QNME)

卖出

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

估值指标

Quanome Technologies, Inc.(QNME)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

QNME 常见问题 —— 由 Alphio AI 解答

Lakeside Holding Limited is a holding company. The Company, through its subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd, is a medical injection and pharmaceutical distributor. It procures products from manufacturers, stores the products at designated warehouses, and distributes them to hospitals, distributors and other healthcare providers, primarily through agents.

Given the current price of 0.38, the stock's RSI is at 37.591, indicating it is oversold. However, the forward P/E ratio is 0, and the gross margin has dropped to 7.96%, which raises concerns about profitability. The stock has seen a 20-day change of -48.35%, suggesting significant downward momentum. Therefore, it is advisable to sell rather than buy at this time.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易